News & Events

In this section

Instem Software Deployed for Translational and Personalized Oncology Programs

Instem Solutions Being Utilized for Testing Efficacy of Established Oncology Drugs While Increasing Speed of Drug Development for BioPharma

CONSHOHOCKEN, PA - (BUSINESS WIRE) - April 17, 2012 - - Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that its integrated Provantis® preclinical software suite has been deployed for a US-based research laboratory specializing in the personalized development and use of oncology drugs by both physicians and patients as well as their BioPharma clients.

Key facts

  • Integrated In-life Toxicology, Protocol, Tables & Statistics and Reporting modules being used  at US-based facility
  • Instem’s Data Import module being used to migrate legacy data seamlessly into Provantis system
  • Provantis chosen to replace existing laboratory information system, offering client more functionality with advanced reporting capabilities
  • Client realized quick and efficient deployment using Instem’s Specialized Solutions Services

“We are pleased to see Provantis being used not only for translational oncology programs for new drug development, but also excited to see Provantis being used for testing established drugs against tumors directly for oncologists and their patients,” comments Gary Mitchell, VP Global Marketing at Instem. “We are eager to expand our footprint in this critical area of personalized medicine and look toward the future with great hope as we join forces with yet another world-class organization that is enhancing and advancing life.”

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

Meeting clients at the intersection of investment & return™.

Press Contacts:

Gary Mitchell (US HQ)
Tel: 610-941-0990

Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600